AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.

Comprising 1,016 Nvidia Blackwell Ultra GPUs, the SuperPOD offers more than 9,000 petaflops of AI performance and will be used to train biomedical foundation and frontier models, reducing drug ...

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering rate, especially among the Mag Seven AI darlings, all while the question ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

SANTA CLARA, CA, UNITED STATES, March 3, 2026 / EINPresswire.com / — OmicInsight, a pioneer in spatial biology, today announced a strategic leadership realignment to accelerate its AI Transformation ...

Liquid AI and Insilico Medicine today announced a partnership that creates lightweight scientific foundation models for pharmaceutical research. The collaboration has produced LFM2-2.6B-MMAI (v0.2.1), ...

Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...

Mayo Clinic, for its part, described the collaboration as its first strategic partnership of this scale with a global ...

Merck & Co. Inc. MRK on Wednesday announced a strategic collaboration with Mayo Clinic to leverage artificial intelligence ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern Medical Research Laboratory. Scientific Lab, Drug Engineering Center Full of ...

Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on private pharmaceutical infrastructure ...